2011 assisted reproductive technology fertility clinic success rates report

For many people who want to start a family, the dream of having a child is not easily realized; about 12% of women of childbearing age in the United States have used an infertility service. Assisted reproductive technology (ART) has been used in the United States since 1981 to help women become pregnant, most commonly through the transfer of fertilized human eggs into a woman\u2019s uterus. However, for many people, deciding whether to undergo this expensive and time-consuming treatment can be difficult.Suggested Citation: Centers for Disease Control and Prevention, American Society for Reproductive Medicine, Society for Assisted Reproductive Technology. 2011 Assisted Reproductive Technology Fertility Clinic Success Rates Report. Atlanta (GA): US Dept of Health and Human Services; 2013.art_2011_clinic_report-full.pdf2013The data included in this report and publication support were provided by Westat under Contract No. GS-23F-8144H for the National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services

2010 assisted reproductive technology fertility clinic success rates report

For many people who want to start a family, the dream of having a child is not easily realized; about 12% of women of childbearing age in the United States have used an infertility service. Assisted reproductive technology (ART) has been used in the United States since 1981 to help women become pregnant, most commonly through the transfer of fertilized human eggs into a woman\u2019s uterus. However, for many people, deciding whether to undergo this expensive and time\u2010consuming treatment can be difficult.Suggested Citation: Centers for Disease Control and Prevention, American Society for Reproductive Medicine, Society for Assisted Reproductive Technology. 2010 Assisted Reproductive Technology Fertility Clinic Success Rates Report. Atlanta: U.S. Department of Health and Human Services; 2012.CS232095ART_2010_Clinic_Report-Full.pdf2012The data included in this report and publication support were provided by Westat under Contract No. 200\u20102004\u201006702 for the National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services

2016 Assisted reproductive technology fertility clinic success rates report

For many people who want to start a family, the dream of having a child is not easily realized. Assisted reproductive technology (ART) has been used in the United States since 1981 to help patients become pregnant, most commonly through the transfer of fertilized human eggs into a woman\u2019s uterus. However, for many people, deciding whether to undergo this expensive and time-consuming treatment can be difficult.The data included in this report and publication support were provided by Westat under Contract No. GS-23F-8144H for the National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, US Department of Health and Human Services.Suggested Citation: Centers for Disease Control and Prevention, American Society for Reproductive Medicine, Society for Assisted Reproductive Technology. 2016 Assisted Reproductive Technology Fertility Clinic Success Rates Report. Atlanta (GA): US Dept of Health and Human Services; 2018.CS291075ART-2016-Clinic-Report-Full.pdf2018Contract No. GS-23F-8144

2013 Assisted reproductive technology fertility clinic success rates report

Acknowledgements to the Centers for Disease Control and Prevention, the Society for Assisted Reproductive Technology, and the American Society for Reproductive Medicine thank RESOLVE: The National Infertility Association and Path2Parenthood (formerly The American Fertility Association) for their commitment to assisted reproductive technology (ART) surveillance.The data included in this report and publication support were provided by Westat under Contract No. GS-23F-8144H for the National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, US Department of Health and Human Services.Suggested citation: Centers for Disease Control and Prevention, American Society for Reproductive Medicine, Society for Assisted Reproductive Technology. 2013 Assisted Reproductive Technology Fertility Clinic Success Rates Report. Atlanta (GA): US Dept of Health and Human Services; 2015.art-2013-fertility-clinic-report.pdf2015GS-23F-8144H736

2014 Assisted reproductive technology fertility clinic success rates report

The Centers for Disease Control and Prevention, the Society for Assisted Reproductive Technology, and the American Society for Reproductive Medicine thank RESOLVE: The National Infertility Association and Path2Parenthood for their commitment to assisted reproductive technology (ART) surveillance. Their assistance in making this report informative and helpful to people considering an ART procedure is greatly appreciated. Appendix D has current contact information for these national consumer organizations.This publication was developed and produced by the National Center for Chronic Disease Prevention and Health Promotion of the Centers for Disease Control and Prevention in consultation with the American Society for Reproductive Medicine and the Society for Assisted Reproductive Technology.The data included in this report and publication support were provided by Westat under Contract No. GS-23F-8144H for the National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, US Department of Health and Human Services.Suggested Citation: Centers for Disease Control and Prevention, American Society for Reproductive Medicine, Society for Assisted Reproductive Technology. 2014 Assisted Reproductive Technology Fertility Clinic Success Rates Report. Atlanta (GA): US Dept of Health and Human Services; 2016.CS270059ART-2014-Clinic-Report-Full.pdfGS-23F-8144

2012 Assisted reproductive technology fertility clinic success rates report

For many people who want to start a family, the dream of having a child is not easily realized; about 12% of women of childbearing age in the United States have used an infertility service. Assisted reproductive technology (ART) has been used in the United States since 1981 to help women become pregnant, most commonly through the transfer of fertilized human eggs into a woman\u2019s uterus. However, for many people, deciding whether to undergo this expensive and time-consuming treatment can be difficult.The goal of this report is to help potential ART users make informed decisions about ART by providing some of the information needed to answer the following questions:\u2022 What are my chances of having a child by using ART?\u2022 Where can I go to get this treatment?The Society for Assisted Reproductive Technology (SART), an organization of ART providers affiliated with the American Society for Reproductive Medicine (ASRM), has been collecting data and publishing annual reports of pregnancy success rates for fertility clinics in the United States and Canada since 1989. In 1992, the US Congress passed the Fertility Clinic Success Rate and Certification Act. This law requires the Centers for Disease Control and Prevention (CDC) to publish pregnancy success rates for ART in fertility clinics in the United States. (For more details about the law, see http://www.cdc.gov/art/Policy.htm.) Since 1995, CDC has worked in consultation with SART and ASRM to report ART success rates.The 2012 report of pregnancy success rates is the eighteenth to be issued under the law. This report is based on the latest available data on the type, number, and outcome of ART cycles performed in US clinics.Suggested citation: Centers for Disease Control and Prevention, American Society for Reproductive Medicine, Society for Assisted Reproductive Technology. 2012 Assisted Reproductive Technology Fertility Clinic Success Rates Report. Atlanta (GA): US Dept of Health and Human Services; 2014.CS247593201

Assisted reproductive technology: prevalence and associated factors in Southern Brazil

OBJECTIVE: To assess the prevalence of successful assisted reproductive technology and to identify the associated factors. METHODS: This population-based birth cohort study was carried out with 4,333 pregnant women expected to deliver in 2015 in the urban area of Pelotas, Southern Brazil. Use of an assisted reproductive technology procedure, type of assisted reproductive technology [in vitro fertilization or intracytoplasmic sperm injection or artificial insemination], number of embryos transferred, success of embryo transfer, number of attempts, and reported reasons for seeking assisted reproductive technology were the main outcomes measured. Use of an assisted reproductive technology procedure was analyzed according to sociodemographic, nutritional, reproductive history, and behavioral characteristics. Unadjusted and adjusted analyses were performed by logistic regression. RESULTS: Among the 4,275 newborns enrolled in the Pelotas 2015 Birth Cohort Study, 18 births (0.4%) were conceived by assisted reproductive technology. Most cases of assisted reproductive technology were by in vitro fertilization (70.6%). All cycles were performed in private clinics under direct out-of-pocket payment. Even after controlling for confounders, maternal age > 35 years, nulliparity and high family monthly income were strongly associated with assisted reproductive technology. CONCLUSIONS: The use of assisted reproductive technology services was reported by only a few women in the Pelotas 2015 Birth Cohort Study. Our study highlights sociodemographic factors associated to assisted reproductive technology procedures. To better understand the patterns and barriers in overall use of assisted reproductive technology services over time, national-level trend studies in assisted reproductive technology treatments and outcomes, as well as studies exploring the characteristics of women who have sought this kind of treatment are needed in low-middle income countries

Fertil Steril

ObjectiveTo evaluate assisted reproductive technology (ART) ET practices in the United States and assess the impact of these practices on multiple births, which pose health risks for both mothers and infants.DesignRetrospective cohort analysis using the National ART Surveillance System data.SettingUS fertility centers reporting to the National ART Surveillance System.Patient(s)Noncanceled ART cycles conducted in the United States in 2012.Intervention(s)None.Main Outcome Measure(s)Multiple birth (birth of two or more infants, at least one of whom was live-born).Result(s)Of 134,381 ART transfer cycles performed in 2012, 51,262 resulted in live births, of which 13,563 (26.5%) were multiple births: 13,123 twin and 440 triplet and higher order births. Almost half (46.1%) of these multiple births resulted from the following four cycle types: two fresh blastocyst transfers among favorable or average prognosis patients less than 35 years (1,931 and 1,341 multiple births, respectively), two fresh blastocyst transfers among donor-oocyte recipients (1,532 multiple births), and two frozen/thawed ETs among patients less than 35 years (1,452 multiple births). More than half of triplet or higher order births resulted from the transfer of two embryos (52.5% of births among fresh autologous transfers, 67.2% of births among donor-oocyte recipient transfers, and 42.9% among frozen/thawed autologous transfers).Conclusion(s)A substantial reduction of ART-related multiple (both twin and triplet or higher order) births in the United States could be achieved by single blastocyst transfers among favorable and average prognosis patients less than 35 years of age and donor-oocyte recipients.CC999999/Intramural CDC HHS/United States2016-04-01T00:00:00Z25637480PMC46070497184vault:1467

Extracellular vesicles, microRNA and the preimplantation embryo: non-invasive clues of embryo well-being

Elective single embryo transfer is rapidly becoming the standard of care in assisted reproductive technology for patients under the age of 35 years with a good prognosis. Clinical pregnancy rates have become increasingly dependent on the selection of a single viable embryo for transfer, and diagnostic techniques facilitating this selection continue to develop. Current progress in elucidating the extracellular vesicle and microRNA components of the embryonic secretome is reviewed, and the potential for these findings to improve clinical embryo selection discussed. Key results have shown that extracellular vesicles and microRNAs are rapidly detectable constituents of the embryonic secretome. Evidence suggests that the vesicular population is largely exosomal in nature, secreted at all stages of preimplantation development and capable of traversing the zona pellucida. Both extracellular vesicle and microRNA concentrations within the secretome are elevated for blastocysts with diminished developmental competence, as indicated either by degeneracy or implantation failure, whereas studies have yet to firmly correlate individual microRNA sequences with pregnancy outcome. These emerging correlations support the viability of extracellular vesicles and microRNAs as the basis for a new diagnostic test to supplement or replace morphokinetic assessment